Bluebird gets European green light for gene therapy production

Bluebird gets European green light for gene therapy production

Source: 
Biopharma Dive
snippet: 

Rare disease drug developer Bluebird bio this week said it secured from European health regulators clearance of new manufacturing specifications for its recently approved gene therapy Zynteglo.